Real-time enrollment status for this hematopoietic and lymphoid cell neoplasm clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:02 PM UTC
| NCT Number | NCT05711667 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Phase | PHASE3 |
| Target Enrollment | 105 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | May 5, 2026 (May 5, 2026) |
As of August 28, 2026: Clinical trial NCT05711667 is currently recruiting participants. This phase3 study for hematopoietic and lymphoid cell neoplasm is actively seeking new participants at 29 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05711667 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05711667 was last updated May 5, 2026 (May 5, 2026). HelloStudys verifies this status automatically.